Aberdeen Group
IMUX icon

Aberdeen Group’s Immunic IMUX Stock Holding History

Aberdeen Group’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7M Sell
824,393
-1
-0% -$12 0.02% 555
2026
Q1 		$9.15M Hold
824,394
– – 0.01% 603
2025
Q4 		$4.4M Hold
824,394
– – 0.01% 711
2025
Q3 		$7.27M Hold
824,394
– – 0.01% 651
2025
Q2 		$5.75M Buy
824,394
+718,446
+678% +$6.6M 0.01% 688
2025
Q1 		$1.15M Buy
+105,948
New +$1.14M ﹤0.01% 805

Other funds holding IMUX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Aberdeen Group's IMUX Position: Q2 2026 in Review

Aberdeen Group reduced its Immunic (IMUX) stake by 0% in Q2 2026, selling an estimated $12 and leaving 824,393 shares worth $12.7M. The position accounts for 0.02% of the portfolio, ranked #555.

Aberdeen Group first reported a position in IMUX in Q1 2025 and has held it in 6 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Aberdeen Group held 824,393 shares of Immunic worth $12.7M as of Q2 2026.
  • Aberdeen Group sold 1 Immunic share in Q2 2026, an estimated $12.
  • Immunic made up 0.02% of Aberdeen Group's portfolio in Q2 2026, its #555 holding.
  • Aberdeen Group first reported a position in Immunic in Q1 2025 and has held it in 6 quarters since.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.